Skip Nav Destination
1-4 of 4
Katarzyna Krzyzanowska, Walter Krugluger, Friedrich Mittermayer, Rupa Rahman, Dominik Haider, Nadja Shnawa, Guntram Schernthaner
Clin Sci (Lond) (2006) 110 (5): 605–609.
Published: 11 April 2006
...Katarzyna Krzyzanowska; Walter Krugluger; Friedrich Mittermayer; Rupa Rahman; Dominik Haider; Nadja Shnawa; Guntram Schernthaner The recently discovered adipocytokine visfatin has insulin-like properties. It lowers blood glucose and improves insulin sensitivity; however, clinical data on visfatin...
Clin Sci (Lond) (2006) 110 (3): 267–278.
Published: 10 February 2006
... excess body energy, but also secretes a variety of bioactive adipocytokines. Obese patients, particularly those with visceral fat accumulation, have reduced plasma levels of adiponectin, the most abundant and adipose-specific adipocytokine. Although the association of adiponectin with several diseases...
Clin Sci (Lond) (2005) 109 (3): 243–256.
Published: 24 August 2005
... in rodent models. In addition, resistin also appears to be a pro-inflammatory cytokine. Taken together, resistin, like many other adipocytokines, may possess a dual role in contributing to disease risk. However, to date there has been considerable controversy surrounding this 12.5 kDa polypeptide...
Clin Sci (Lond) (2004) 107 (6): 519–532.
Published: 24 November 2004
... resistance and endothelial dysfunction. In recent years, it has become apparent that insulin sensitivity is regulated by the adipocytokines, a group of bioactive proteins secreted by adipose tissue. Secretion of adipocytokines is altered in obese individuals and there is increasing evidence...